Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Chord Energy
CHRD
$7.68B
| $21.2M | 0.02% |
1,338,631
+3,519
| +0.3% | +$59.2K |
|
452
Prothena Corp
PRTA
$448M
| $21.2M | 0.02% |
401,730
-174,562
| -30% | -$6.89M |
|
|
ISBC
453
DELISTED
Investors Bancorp, Inc.
ISBC
| $21.1M | 0.02% |
1,715,506
+70,217
| +4% | +$848K |
|
454
CALL
Cigna
CI
$78.4B
| $21.1M | 0.02% |
130,000
| – | – |
|
455
Bloomin' Brands
BLMN
$754M
| $21M | 0.02% |
985,119
+961,351
| +4,045% | +$21.6M |
|
456
Cheniere Energy
CQP
$30.5B
| $20.9M | 0.02% |
676,025
+11,192
| +2% | +$360K |
|
457
United Natural Foods
UNFI
$3.04B
| $20.2M | 0.02% |
316,876
+46,671
| +17% | +$3.16M |
|
458
CALL
Centene
CNC
$30.5B
| $20.1M | 0.02% |
500,000
| – | – |
|
|
NSA
459
DELISTED
National Storage Affiliates Trust
NSA
| $20.1M | 0.02% |
+1,617,348
| New | +$21.2M |
|
460
BioCryst Pharmaceuticals
BCRX
$2.42B
| $19.7M | 0.02% |
1,317,717
+344,618
| +35% | +$3.92M |
|
|
MKTO
461
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $19.5M | 0.02% |
694,010
+90,770
| +15% | +$2.61M |
|
|
SGMO
462
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $19.2M | 0.02% |
1,731,499
+13,577
| +0.8% | +$175K |
|
|
BECN
463
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $19.2M | 0.02% |
576,976
+130,954
| +29% | +$4.12M |
|
464
CALL
Humana
HUM
$43.9B
| $19.1M | 0.02% |
100,000
| – | – |
|
|
DBVT
465
DBV Technologies
DBVT
$813M
| $18.8M | 0.02% |
62,962
+91
| +0.1% | +$23.5K |
|
|
PKY
466
DELISTED
Parkway, Inc.
PKY
| $18.6M | 0.02% |
1,068,807
+159,435
| +18% | +$2.73M |
|
467
PUT
Biogen
BIIB
$30.9B
| $18.1M | 0.02% |
44,800
| – | – |
|
468
Agios Pharmaceuticals
AGIO
$2.08B
| $17.6M | 0.02% |
157,949
+1,272
| +0.8% | +$137K |
|
|
VSLR
469
DELISTED
VIVINT SOLAR, INC.
VSLR
| $17.2M | 0.02% |
1,415,607
| – | – |
|
|
SPNC
470
DELISTED
Spectranetics Corp
SPNC
| $17.1M | 0.02% |
741,754
-73,171
| -9% | -$2.04M |
|
471
Glaukos
GKOS
$9.49B
| $16.8M | 0.02% |
+580,630
| New | +$16.9M |
|
472
IMAX
IMAX
$2.67B
| $16.7M | 0.02% |
415,214
-101,443
| -20% | -$3.94M |
|
|
ZOES
473
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $16.7M | 0.02% |
407,955
-11,022
| -3% | -$384K |
|
|
CIM
474
Chimera Investment
CIM
$1.06B
| $16.6M | 0.02% |
404,611
+19,863
| +5% | +$887K |
|
475
Xencor
XNCR
$1.45B
| $16.6M | 0.02% |
755,505
+4,997
| +0.7% | +$85.2K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.